Tax Credit Carryforward, Deferred Tax Asset, Net of Valuation Allowance
Edwards Lifesciences·Geographic·1 segment
Breakdown
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Other countries | $0.00 | $500.00K | $700.00K | $6.00M | $0.00 |
| Total | $0.00 | $500.00K | $700.00K | $6.00M | $0.00 |
Segments
Other countriesView metric